MB
MBX Biosciences, Inc. Common Stock (MBX)
NASDAQ·Healthcare·Biotechnology
$64.30
+7.05%
Mkt Cap $1.96B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (12 analysts)
$71.50
Range $56.00 – $90.00
Implied Upside
+11.2%
Consensus $71.50 vs current $64.30